Pharmacologic Treatment of Cancer-Related Fatigue
Open Access
- 1 May 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 12 (S1) , 43-51
Abstract
Fatigue is the most commonly reported symptom in patients with cancer, with a prevalence of over 60% reported in the majority of studies. This paper systematically reviews pharmacologic agents in the treatment of cancer-related fatigue (CRF). We conducted a literature review of clinical trials that assessed pharmacologic agents for the treatment of CRF. These agents include hematopoietics (for anemia), corticosteroids, and psychostimulants. Other therapeutic agents that are less well studied for CRF but are currently the focus of clinical trials include l-carnitine, modafinil, bupropion, and selective serotonin reuptake inhibitors such as paroxetine. Disclosure of potential conflicts of interest is found at the end of this article.Keywords
Funding Information
- National Cancer Institute (1R25-CA102618-01A1, 2U10 CA037420-20)
- American Cancer Society (RSG01071-01-PBP, MRSG-04-233-01-CPPB)
- Cephalon, Inc., Frazer, PA
This publication has 69 references indexed in Scilit:
- Efficacy of Darbepoetin Alfa in Alleviating Fatigue and the Effect of Fatigue on Quality of Life in Anemic Patients with Lymphoproliferative MalignanciesJournal of Pain and Symptom Management, 2006
- Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Multicenter German TrialThe Oncologist, 2005
- A Neuroendocrine-Based Regulatory Fatigue ModelBiological Research For Nursing, 2004
- A randomized, active‐control, pilot trial of front‐loaded dosing regimens of darbepoetin‐alfa for the treatment of patients with anemia during chemotherapy for malignant diseaseCancer, 2003
- Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's diseaseMovement Disorders, 2002
- Interferon-Induced Fatigue in Patients With Melanoma: A Pilot Study of Exercise and MethylphenidateOncology Nursing Forum, 2002
- Fatigue associated with cancer and its treatmentSupportive Care in Cancer, 2001
- Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot studyAmerican Journal of Hospice and Palliative Medicine®, 2001
- Anaemia in cancer: pathophysiology and treatmentCancer Treatment Reviews, 2000
- Epoetin AlfaDrugs, 1995